Ollier M - Search Results

1

High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers.

Favre L, Cohen J, Calderaro J, Pécriaux A, Nguyen CT, Bourgoin R, Larnaudie L, Dupuy A, Ollier M, Lechapt E, Sloma I, Tournigand C, Rousseau B, Pujals A. Favre L, et al. Among authors: ollier m. Mol Oncol. 2022 Sep;16(17):3055-3065. doi: 10.1002/1878-0261.13257. Epub 2022 Jul 14. Mol Oncol. 2022. PMID: 35624529 Free PMC article.

2

Subcellular distribution of a new fluorinated, biocompatible, non-ionic telomeric carrier: a study in cultured B16 melanoma and rat skin fibroblasts.

Chehade F, Maurizis JC, Pucci B, Pavia AA, Ollier M, Veyre A, Escaig F, Jeanguillaume C, Dennebouy R, Slodzian G, Hindié E. Chehade F, et al. Among authors: ollier m. Cell Mol Biol (Noisy-le-grand). 1996 May;42(3):335-42. Cell Mol Biol (Noisy-le-grand). 1996. PMID: 8793188

3

Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest.

Es-saady D, Simon A, Ollier M, Maurizis JC, Chulia AJ, Delage C. Es-saady D, et al. Among authors: ollier m. Cancer Lett. 1996 Sep 10;106(2):193-7. doi: 10.1016/0304-3835(96)04312-1. Cancer Lett. 1996. PMID: 8844972

4

In vitro binding of oxime acetylcholinesterase reactivators to proteoglycans synthesized by cultured chondrocytes and fibroblasts.

Maurizis JC, Ollier M, Nicolas C, Madelmont JC, Garrigue H, Veyre A. Maurizis JC, et al. Among authors: ollier m. Biochem Pharmacol. 1992 Nov 17;44(10):1927-33. doi: 10.1016/0006-2952(92)90094-y. Biochem Pharmacol. 1992. PMID: 1449512

5

Biodistribution and metabolism in rats and mice of bucromarone.

Maurizis JC, Nicolas C, Verny M, Ollier M, Faurie M, Payard M, Veyre A. Maurizis JC, et al. Among authors: ollier m. Drug Metab Dispos. 1991 Jan-Feb;19(1):94-9. Drug Metab Dispos. 1991. PMID: 1673429

6

New quaternary ammonium oxicam derivatives targeted toward cartilage: synthesis, pharmacokinetic studies, and antiinflammatory potency.

Nicolas C, Verny M, Giraud I, Ollier M, Rapp M, Maurizis JC, Madelmont JC. Nicolas C, et al. Among authors: ollier m. J Med Chem. 1999 Dec 16;42(25):5235-40. doi: 10.1021/jm991120o. J Med Chem. 1999. PMID: 10602708

7

Joint scintigraphy in rabbits with 99mtc-N-[3-(triethylammonio)propyl]-15ane-N5, a new radiodiagnostic agent for articular cartilage imaging.

Ollier M, Maurizis JC, Nicolas C, Bonafous J, de Latour M, Veyre A, Madelmont JC. Ollier M, et al. J Nucl Med. 2001 Jan;42(1):141-5. J Nucl Med. 2001. PMID: 11197964 Free article.

8

In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.

Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. Maublant JC, et al. Among authors: ollier m. J Nucl Med. 1993 Nov;34(11):1949-52. J Nucl Med. 1993. PMID: 8229240 Free article.

9

Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammonium-propyl-cyclam, and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agents.

Maurizis JC, Rapp M, Nicolas C, Ollier M, Verny M, Madelmont JC. Maurizis JC, et al. Among authors: ollier m. Drug Metab Dispos. 2000 Apr;28(4):418-22. Drug Metab Dispos. 2000. PMID: 10725310

10

Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.

Pereira ER, Belin L, Sancelme M, Prudhomme M, Ollier M, Rapp M, Sevère D, Riou JF, Fabbro D, Meyer T. Pereira ER, et al. Among authors: ollier m. J Med Chem. 1996 Oct 25;39(22):4471-7. doi: 10.1021/jm9603779. J Med Chem. 1996. PMID: 8893841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters